Filing Details

Accession Number:
0001209191-19-015224
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-01 19:41:12
Reporting Period:
2019-02-27
Accepted Time:
2019-03-01 19:41:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI Pharmaceutical Preparations (2834) 364742850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585697 J. Lawrence Hineline C/O Intra-Cellular Therapies, Inc.
430 East 29Th Street
New York NY 10016
Svp Of Finance Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-27 10,000 $2.74 25,832 No 4 M Direct
Common Stock Acquisiton 2019-02-27 400 $2.74 26,232 No 4 M Direct
Common Stock Disposition 2019-02-27 1,000 $15.00 25,232 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-02-27 10,000 $0.00 10,000 $2.74
Common Stock Stock Option (right to buy) Disposition 2019-02-27 400 $0.00 400 $2.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-21 No 4 M Direct
9,600 2020-06-10 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2018.
  2. All shares underlying this option have vested.